The enormous number of Plasmodium falciparum infections in the world act to generate a vast reservoir of genetic variants, which can influence the pathogenesis, virulence, and drug sensitivity of these parasites. It is generally believed that P. Falciparum isolates are panmixic, i.e., mating randomly in the population. Recent work, however, indicates a pattern of nonrandom mating in some parts of the world. Furthermore, an investigation of maternally inherited cytoplasmic markers in a laboratory cross of well-characterized P. Falciparum clones HB3 and 3D7 revealed unidirectional mating in which the 3D7 clone dominated as the maternal parent. The prevalence of such mating behavior among various geographically distant P. Falciparum strains is unknown at present. Instances of unidirectional cytoplasmic incompatibility are known in many different species, and are often mediated by elements that cause genetic instability and hybrid dysgenesis in unidirectional manner. This often portends early stages of speciation. Hence, an understanding of mating compatibility among various P. Falciparum strains is important in the pursuit of knowledge regarding the emerging and reemerging global malaria situation. The hypothesis under which this project will operate states that P. Falciparum strains are undergoing nonrandom mating, and that unidirectional incompatibility affects parasite mating behavior. It is further hypothesized that a regulated genetic instability is an underlying factor that drives the incompatible mating behavior. Nonrandom mating could have a major impact on the spread of multi- locus traits such as the responses to immune surveillance and drug treatment within the parasite population.
Three specific aims i nvolving relatively straightforward approaches, but requiring labor intensive work, are proposed.
In aim 1, cross-mating between well characterized P. Falciparum clones from Central America (HB3), Africa (3D7), Southeast Asia (W2), and South America (7G8) will be carried out, and the hybrid oocysts examined for their maternal lineage and directionality of the mating.
In aim 2, independent recombinant progeny of the HB3 X 3D7 cross will be backcrossed to the HB3 parent to examine the possible nuclear locus that may dictate unidirectional mating.
In aim 3, a genetic linkage map of the HB3 X 3D7 map will be derived using simple sequence length polymorphism markers. The map will aid in positional identification of the genes responsible for important biological properties of P. falciparum.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041879-06
Application #
6373702
Study Section
Special Emphasis Panel (ZRG5-BM-2 (03))
Program Officer
Gottlieb, Michael
Project Start
1997-08-01
Project End
2003-07-31
Budget Start
2001-08-01
Budget End
2003-07-31
Support Year
6
Fiscal Year
2001
Total Cost
$319,314
Indirect Cost
Name
Mcp Hahnemann University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19102
Vaidya, Akhil B (2018) Reflections on an inflection: From virology to parasitology guided by POLARIS. PLoS Pathog 14:e1006941
Alkhalil, Abdulnaser; Pillai, Ajay D; Bokhari, Abdullah A B et al. (2009) Complex inheritance of the plasmodial surface anion channel in a Plasmodium falciparum genetic cross. Mol Microbiol 72:459-69
Kaiser, Karine; Camargo, Nelly; Coppens, Isabelle et al. (2004) A member of a conserved Plasmodium protein family with membrane-attack complex/perforin (MACPF)-like domains localizes to the micronemes of sporozoites. Mol Biochem Parasitol 133:15-26
Bhattacharyya, M K; Kumar, N (2001) Effect of xanthurenic acid on infectivity of Plasmodium falciparum to Anopheles stephensi. Int J Parasitol 31:1129-33
Lobo, C A; Dhar, R; Kumar, N (1999) Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Infect Immun 67:1688-93
Shi, Y P; Hasnain, S E; Sacci, J B et al. (1999) Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A 96:1615-20